Drug intelligence / Profile preview

inulin + arabinoxylan

Development stage: Preclinical
Lead developer: BioActor
Modality: Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Small Molecules, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

Inulin + arabinoxylan is a combination of two dietary fibers, inulin and arabinoxylan, used primarily as a prebiotic supplement. Inulin is a naturally occurring polysaccharide found in many plants (such as chicory root, onions, and asparagus), while arabinoxylan is derived from cereal grains like wheat and rye. This combination has been studied for its effects on the gut microbiome and metabolic health. Mechanistically, both fibers are fermented by gut bacteria to produce short-chain fatty acids (SCFAs), which can influence energy intake and support beneficial microbial populations such as Bifidobacteria and Lactobacilli. A recent clinical study showed that daily supplementation with this blend reduced calorie intake during meals without affecting subjective appetite or satiety but increased SCFA production and beneficial gut bacteria counts[2]. The product Naxus by BioActor contains this specific blend.

Brand names: Naxus

Beyond the preview

Go deeper on inulin + arabinoxylan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inulin + arabinoxylan.

Explore the full profile